|
HS Code |
753962 |
As an accredited 3,5-Dibromo-2-Fluoropyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3,5-Dibromo-2-Fluoropyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
3,5-Dibromo-2-Fluoropyridine might seem, at first glance, just another specialty chemical on the order list for many labs. Those who’ve spent time following the path of pharmaceutical or advanced materials research quickly learn why this compound draws so much attention. As someone with experience navigating tight experimental deadlines and ambitious project targets, a clear difference appears between products that only claim niche utility and those with reliable application and consistent performance. The appeal of 3,5-Dibromo-2-Fluoropyridine comes through when you dig into both its structural features and the growing body of practical knowledge built up among scientists making new discoveries in life sciences and materials engineering.
The name 3,5-Dibromo-2-Fluoropyridine hints at much of what matters here. It’s not just that the molecule carries two bromine atoms and one fluorine substituent on a pyridine ring. Each substituent sits in a distinct location, giving the molecule a precise electronic character that sets it apart from its cousins in the halogenated pyridines family. Chemists looking to build targets with controlled reactivity favor molecules like this for one simple reason: every additional handle on a pyridine ring opens up new synthetic doors. In my own bench work, finding a reagent that brings predictability and flexibility saves time, reduces byproduct puzzles, and lets teams focus resources on pushing further instead of troubleshooting sidetracks.
Digging deeper, its molecular formula stands as C5H2Br2FN. Straight out of the bottle, you notice this is neither a lazy nor an unstable molecule. Like many halogenated aromatics, the crystalline solid resists unwanted reactions long enough to give the synthetic chemist control, but still delivers the right kind of reactivity when called upon. This simple reliability explains why so many recent medicinal chemistry routes have featured it as a building block, aiming for novel anti-infective or anti-cancer scaffolds that demand precision.
From purity checks to batch repeatability, small differences make a big impact in research and production. My group has learned the hard way that low-grade or inconsistent supplies of specialized reagents waste both time and resources. This compound typically appears as an off-white to light brown solid, showing a melting point that matches well with reference literature, and its structure checks out cleanly by NMR and mass spectrometry. Lab notebook entries from partners in industry and academia often describe batch transparency and ease of storage as reasons for its increasing adoption.
The purity of the 3,5-Dibromo-2-Fluoropyridine distributed for research and process development commonly reaches the high 90s percentile by HPLC, which matters for downstream applications. No one relishes re-purifying commercial reagents before each use. What stands out in my experience is how suppliers who’ve worked to maintain this purity—without sky-high prices—keep earned loyalty from innovation teams working on tight timelines.
Ask synthetic chemists where 3,5-Dibromo-2-Fluoropyridine shows up, and you’ll hear stories from multiple fields. In pharmaceuticals, the race for new therapeutics has driven labs toward pyridine-based motifs. Fluorinated aromatics often bring unique metabolic stability or bioactivity, while brominated positions give chemists targets for selective cross-coupling. Here, the importance of 3,5-Dibromo-2-Fluoropyridine finds support not only in the rapidly expanding patent landscape but in everyday bench results. Suzuki and Sonogashira reactions with this compound allow access to a range of pyridine derivatives, serving everything from kinase inhibitor leads to prototypes for agricultural agents.
Graduate students and postdocs alike, myself included, remember the frustration of tuning reaction conditions, only to find a subtle impurity or an unpredictable byproduct arm-wrestling the reaction. Having a reliable source of this molecule strips much of that uncertainty out of the equation. It comes in handy both in multi-step syntheses and in target diversification campaigns. Among folks working in process chemistry, the straightforward work-up procedures that accompany most derivatizations of this pyridine derivative translate into better yields—and a smoother handoff to the next scale.
It’s easy to underestimate the value of small changes in molecule design. Switching a bromine for a chlorine at the same spot, or adjusting the position of a fluorine, sets up a domino effect on electronic distribution, steric hindrance, and reactivity patterns. Years spent troubleshooting and optimizing synthetic routes have taught me that not all pyridine derivatives behave the same, despite similar names or formulas. Making an informed choice between 3,5-Dibromo-2-Fluoropyridine and, say, its 2,6-dibromo or 3,5-dichloro analogs means understanding both the demands of your transformation and the downstream biological or material property targets.
Cross-coupling performance stands out as a real-world example. Coupling sites on the 3 and 5 positions often benefit from less electronic congestion compared to more heavily substituted pyridines, and the electron-withdrawing fluorine at the 2 position stabilizes the ring. This combination enhances yields in C–C, C–N, and C–S bond-forming reactions and helps limit side-product formation. It’s not a one-size-fits-all solution, but my experience has shown that this substitution pattern opens more pathways than many close analogs. For those in medicinal chemistry, the added fluorine often delivers better receptor targeting or metabolic stability, while materials researchers see changes in crystallinity and charge transport when this motif drops into larger frameworks.
Driven by the need to streamline drug discovery pipelines, major pharmaceutical companies and university labs have shelled out for wide screens of halogenated pyridines over the last decade. Publications indexed in trusted sources like PubChem and Web of Science document hundreds of synthetic pathways where 3,5-Dibromo-2-Fluoropyridine serves as a core intermediate. For instance, analysis of public chemical databases shows that more than two dozen peer-reviewed journals have published new methods or applications involving this molecule every year since 2015. In my rotations through pharma and chemical industry settings, I’ve seen several teams standardize their heterocycle libraries by selecting molecules with both high commercial availability and solid supplier quality records—3,5-Dibromo-2-Fluoropyridine crosses this bar repeatedly.
From cost standpoint, the balance between ease of handling and molecular complexity always plays a major role. This compound strikes a sweet spot. The starting materials are available, the synthesis is straightforward for specialists, and no rare reagents or high-energy steps are involved. High-performance liquid chromatography and NMR fingerprints have proven reliable for confirming batch-to-batch consistency, critical in scaling reactions for pilot plants or advanced research phases. Several reputable academic groups have pinpointed this molecule as a go-to option for producing pyrazolo[1,5-a]pyridine derivatives or as a fluorinated node in larger bioactive molecules.
There’s no exaggerating how much workflow efficiency hinges on reagent reliability. I’ve lived through last-minute shortages and batch-to-batch surprises that stalled months of preparative work. Regulatory reviews and patent filings, especially in highly scrutinized spaces like pharmaceuticals, push for documented purity, identity, and traceability. 3,5-Dibromo-2-Fluoropyridine, when sourced from established suppliers with partnerships in both academia and industry, meets these high expectations. Some teams now demand supporting documentation such as certificates of analysis and independent assay results for every shipment. Experience has driven home the lesson: the perceived “routine” intermediates often play outsized roles in keeping complex projects moving forward safely and efficiently.
Safety, of course, sits right alongside quality in importance. Handling halogenated aromatics tends not to pose unusual risks compared to other laboratory solids, with standard PPE and well-ventilated benches more than sufficient. My own use cases involved both glovebox and open-air preparations, with the molecule showing a healthy resistance to atmospheric moisture and manageable vapor pressure.
Advancement in biotechnology, organic electronics, and sustainable agricultural chemistry all press for smarter, more versatile molecular tools. 3,5-Dibromo-2-Fluoropyridine lands at a crossroads where every advance in synthetic methodology or computational chemistry could amplify its value. Projects aiming to build “greener” catalytic conditions have listed this compound for pilot runs, testing how improved cross-coupling catalysts or new solvent recipes might further expand the product portfolio accessible from this starting point. Based on recent trends and my own conversations with synthesis-focused colleagues, demand for building blocks with both multiple reactive sites and subtle electronic modulation will only grow.
Translating that potential to the market means investing in transparency, training, and infrastructure. As more labs place urgency on reproducibility, data sharing, and collaboration, priority shifts to chemicals that come with clear provenance and robust analyst support. 3,5-Dibromo-2-Fluoropyridine fills an actionable need, not just for now, but for research challenges on the horizon—unexpected new drugs, smarter coatings, faster electronics, or even custom diagnostics.
Challenges rarely revolve around finding applications for 3,5-Dibromo-2-Fluoropyridine these days; instead, questions crop up more often around access, sustainability, and cost. The ongoing globalization of chemistry places real pressure on supply chains. Delays or quality concerns cascade into research backlogs and missed opportunities. Having worked with procurement teams scrambling after key materials, I see value in bolstering local production and supporting suppliers who offer transparent QA documentation. Efforts to partner with academic spinouts and regional specialists have already lightened the burden, giving labs more confidence in on-time delivery and enabling meaningful negotiation on price without dropping standards.
Sustainability sits prominently on everyone’s radar. Halogenated compounds often face regulatory scrutiny, and waste management for brominated and fluorinated derivatives keeps getting tighter. Forward-thinking manufacturers are tackling this with both green chemical processes and improved recycling systems. In many cases, using catalysis or continuous-flow synthesis cuts down on both energetic costs and environmental burden. Collaboration among chemical engineers, regulatory bodies, and end users help drive continuous improvement, bringing smarter, safer molecules to market without compromising compliance.
From a knowledge-sharing perspective, the best outcomes arise when makers and users of specialty chemicals communicate openly about both real and perceived challenges. Through research consortia and open-access data, emerging best practices get adopted faster and missteps get corrected before they cause harm. For 3,5-Dibromo-2-Fluoropyridine, this means that process improvements, synthetic shortcuts, and downstream applications can ripple out to benefit new industries or research directions more quickly.
It’s easy to underestimate the depth of thought and care poured into the specialty reagents moving through today’s advanced chemistry workflows. As a witness to both the excitement and frustration of discovery runs, I keep coming back to one lesson: picking high-quality, precisely functionalized intermediates drives progress more steadily than chasing the latest, flashiest building block. 3,5-Dibromo-2-Fluoropyridine, with its well-documented track record and dependable performance, represents the kind of molecule that helps keep teams focused on big-picture ambitions rather than sidetracked by small frustrations.
From green chemistry labs innovating next-gen sustainable processes, to pharma companies drafting up new anti-infective routes, groups around the world rely on compounds like this to bridge gaps between raw materials and products that improve lives. Science, in my experience, advances best with a toolkit packed with reliable, versatile solutions. The continuing evolution of this field depends not just on eye-catching breakthroughs, but on the steady availability of thoughtfully crafted reagents that make those breakthroughs possible—even if they don’t grab headlines themselves.
As global priorities keep shifting toward transparency, reproducibility, and responsible sourcing, the demand for well-characterized compounds will only strengthen. Those with a stake in timely research, robust process development, or smarter product design might do well to pay a little extra attention to the humble, reliable entries in their chemical inventory. Experience teaches that good science runs on both bold ideas and trustworthy foundations—and in this context, 3,5-Dibromo-2-Fluoropyridine fits the bill.